116 related articles for article (PubMed ID: 32916418)
1. Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02.
von Achenbach C; Le Rhun E; Sahm F; Wang SS; Sievers P; Neidert MC; Rushing EJ; Lawhon T; Schneider H; von Deimling A; Weller M
Transl Oncol; 2020 Dec; 13(12):100852. PubMed ID: 32916418
[TBL] [Abstract][Full Text] [Related]
2. Profound, durable and MGMT-independent sensitivity of glioblastoma cells to cyclin-dependent kinase inhibition.
Le Rhun E; von Achenbach C; Lohmann B; Silginer M; Schneider H; Meetze K; Szabo E; Weller M
Int J Cancer; 2019 Jul; 145(1):242-253. PubMed ID: 30549269
[TBL] [Abstract][Full Text] [Related]
3. Targeting of cyclin-dependent kinases in atypical teratoid rhabdoid tumors with multikinase inhibitor TG02.
Ding AS; Huq S; Casaos J; Raj D; Morales M; Zhao T; Kim T; Srivastava S; Pant A; Serra R; Gorelick NL; Brem H; Tyler B
J Neurosurg Pediatr; 2021 Sep; 28(6):734-743. PubMed ID: 34479190
[TBL] [Abstract][Full Text] [Related]
4. Interferon-β sensitizes human glioblastoma cells to the cyclin-dependent kinase inhibitor, TG02.
Lohmann B; Le Rhun E; Silginer M; Epskamp M; Weller M
Oncol Lett; 2020 Apr; 19(4):2649-2656. PubMed ID: 32218815
[TBL] [Abstract][Full Text] [Related]
5. TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties.
Goh KC; Novotny-Diermayr V; Hart S; Ong LC; Loh YK; Cheong A; Tan YC; Hu C; Jayaraman R; William AD; Sun ET; Dymock BW; Ong KH; Ethirajulu K; Burrows F; Wood JM
Leukemia; 2012 Feb; 26(2):236-43. PubMed ID: 21860433
[TBL] [Abstract][Full Text] [Related]
6. Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation.
Peyre M; Stemmer-Rachamimov A; Clermont-Taranchon E; Quentin S; El-Taraya N; Walczak C; Volk A; Niwa-Kawakita M; Karboul N; Giovannini M; Kalamarides M
Oncogene; 2013 Sep; 32(36):4264-72. PubMed ID: 23045274
[TBL] [Abstract][Full Text] [Related]
7. The multi-kinase inhibitor TG02 overcomes signalling activation by survival factors to deplete MCL1 and XIAP and induce cell death in primary acute myeloid leukaemia cells.
Pallis M; Abdul-Aziz A; Burrows F; Seedhouse C; Grundy M; Russell N
Br J Haematol; 2012 Oct; 159(2):191-203. PubMed ID: 22934750
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
9. Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.
Gupta V; Su YS; Samuelson CG; Liebes LF; Chamberlain MC; Hofman FM; Schönthal AH; Chen TC
J Neurosurg; 2007 Mar; 106(3):455-62. PubMed ID: 17367069
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
[TBL] [Abstract][Full Text] [Related]
11. Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.
Hankins GR; Sasaki T; Lieu AS; Saulle D; Karimi K; Li JZ; Helm GA
Neurosurgery; 2008 Oct; 63(4):771-80; discussion 780-1. PubMed ID: 18981889
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome.
Korshunov A; Shishkina L; Golanov A
Int J Cancer; 2003 May; 104(6):728-34. PubMed ID: 12640680
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSF1A.
Nakane Y; Natsume A; Wakabayashi T; Oi S; Ito M; Inao S; Saito K; Yoshida J
J Neurosurg; 2007 Aug; 107(2):398-404. PubMed ID: 17695396
[TBL] [Abstract][Full Text] [Related]
14. HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas.
Di Vinci A; Brigati C; Casciano I; Banelli B; Borzì L; Forlani A; Ravetti GL; Allemanni G; Melloni I; Zona G; Spaziante R; Merlo DF; Romani M
Transl Res; 2012 Nov; 160(5):355-62. PubMed ID: 22735029
[TBL] [Abstract][Full Text] [Related]
15. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma.
Paramasivam N; Hübschmann D; Toprak UH; Ishaque N; Neidert M; Schrimpf D; Stichel D; Reuss D; Sievers P; Reinhardt A; Wefers AK; Jones DTW; Gu Z; Werner J; Uhrig S; Wirsching HG; Schick M; Bewerunge-Hudler M; Beck K; Brehmer S; Urbschat S; Seiz-Rosenhagen M; Hänggi D; Herold-Mende C; Ketter R; Eils R; Ram Z; Pfister SM; Wick W; Weller M; Grossmann R; von Deimling A; Schlesner M; Sahm F
Acta Neuropathol; 2019 Aug; 138(2):295-308. PubMed ID: 31069492
[TBL] [Abstract][Full Text] [Related]
16. Dual inhibition of Mcl-1 by the combination of carfilzomib and TG02 in multiple myeloma.
Ponder KG; Matulis SM; Hitosugi S; Gupta VA; Sharp C; Burrows F; Nooka AK; Kaufman JL; Lonial S; Boise LH
Cancer Biol Ther; 2016 Jul; 17(7):769-77. PubMed ID: 27246906
[TBL] [Abstract][Full Text] [Related]
17. Expression of survivin and p16(INK4a)/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells.
Al-Khalaf HH; Lach B; Allam A; Hassounah M; Alkhani A; Elkum N; Alrokayan SA; Aboussekhra A
Brain Res; 2008 Jan; 1188():25-34. PubMed ID: 18048012
[TBL] [Abstract][Full Text] [Related]
18. Is DNA Methylation a Ray of Sunshine in Predicting Meningioma Prognosis?
Shen L; Lin D; Cheng L; Tu S; Wu H; Xu W; Pan Y; Wang X; Zhang J; Shao A
Front Oncol; 2020; 10():1323. PubMed ID: 33014773
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
[TBL] [Abstract][Full Text] [Related]
20. Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas.
Mawrin C; Sasse T; Kirches E; Kropf S; Schneider T; Grimm C; Pambor C; Vorwerk CK; Firsching R; Lendeckel U; Dietzmann K
Clin Cancer Res; 2005 Jun; 11(11):4074-82. PubMed ID: 15930342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
